Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.120
- 0.0000.00%
20min DelayMarket Closed May 1 15:51 AET
59.08MMarket Cap-5.71P/E (Static)
0.125High0.120Low445.61KVolume0.120Open0.120Pre Close54.87KTurnover0.24552wk High0.13%Turnover Ratio492.31MShares0.09652wk Low-0.021EPS TTM42.16MFloat Cap0.245Historical HighLossP/E (Static)351.37MShs Float0.096Historical Low-0.021EPS LYR4.17%Amplitude--Dividend TTM5.00P/B1Lot Size--Div YieldTTM
Neurizon Therapeutics Ltd News
Neurizon Therapeutics Ltd: Notice of Quarterly Shareholder Update Webinar
Neurizon Therapeutics Ltd: Appointment of Chief Financial Officer
Neurizon Therapeutics Ltd: Leadership team strengthened with strategic appointments
Neurizon Therapeutics Ltd: NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
Neurizon Therapeutics Ltd: NUZ-001 Shows Positive Results in Human 3D Brain Model
Neurizon Therapeutics Ltd: NUZ-001 shows promising respiratory outcome
Neurizon Therapeutics Ltd: Neurizon Commences Initiatives to Lift Clinical Hold
Neurizon Therapeutics Ltd: FDA Guidance on NUZ-001 IND Application
Neurizon Therapeutics Ltd: Notice of Company Update Webinar
Neurizon Therapeutics Ltd: US Patent granted for NUZ-001
Neurizon Therapeutics Ltd: Neurizon updates on NUZ-001 IND Application
Neurizon Therapeutics Ltd: Change of Share Registry
Neurizon Therapeutics Ltd: Neurizon Files IND Application to Support HEALEY ALS Trial
Neurizon Therapeutics Ltd: Neurizon Granted OMPD for NUZ-001 in Europe
Neurizon Therapeutics Ltd: Positive 8-month Interim Data from OLE Study
Neurizon Therapeutics Ltd: Neurizon Receives Additional R&D Tax Incentive Rebate
Neurizon Therapeutics Ltd: Notice of Company Update Webinar
Neurizon Therapeutics Ltd: Correction to text positioning error in announcement
Neurizon Therapeutics Ltd: NUZ-001 Reduces Aggregation of Key ALS Disease Target
Neurizon Therapeutics Ltd: Positive opinion received on OMPD for NUZ-001 in Europe
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts